Epoetin beta biosimilar (Veropharm)

促红素β生物类似药 (Veropharm)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin beta biosimilar (Veropharm)

Drug Alias Name依泊汀β生物仿制药 (Veropharm)促红素β生物仿制药 (Veropharm)倍他依泊汀物仿制药 (Veropharm)Vero-epoetin

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists

TargetsErythropoietin receptor

Therapy Area/IndicationsAnemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesAbbott Laboratories

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsAnemia

Inactive IndicationsN/A

ATC CodeB03XA01